Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

IRDye 800CW-conjugated panitumumab

Based on

1 Articles
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

panitumumab

Type Biomolecule
Formula
Role raw materials
2

IRDye 800CW NHS ester

IRDye800 NHS ester IR800 NHS ester IRDye 800CW NHS IR800
Type Single Compound
Formula C50H54N3Na3O17S4
Role raw materials

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
A431 tumor-bearing homozygote athymic nude mouse

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • IRDye 800CW NHS ester
  • panitumumab
  1. SN8X1O8C8nYpmEskuuNrC2sVCvlUL6JcbsEZe07aJdRbMPKU9Z
  2. 0s6
Product

IRDye 800CW-conjugated panitumumab

Size: 10 - 200 nm

Medium/Support: none

Method 2

Type: Purification
Source:
Starting materials
  • IRDye 800CW-conjugated panitumumab
  1. oTqWhN72yMTIuHFhsjYOEoTYH8l39YVWNG4rcuhtc
Product

IRDye 800CW-conjugated panitumumab

Size: 10 - 200 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial